SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020484
Filing Date
2018-11-13
Accepted
2018-11-13 11:07:56
Documents
82
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20180930_10q.htm 10-Q 723883
2 EXHIBIT 31.1 ex_129339.htm EX-31.1 8954
3 EXHIBIT 31.2 ex_129340.htm EX-31.2 8896
4 EXHIBIT 32.1 ex_129341.htm EX-32.1 6011
5 EXHIBIT 32.2 ex_129342.htm EX-32.2 6384
  Complete submission text file 0001437749-18-020484.txt   4740758

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cenb-20180930.xml EX-101.INS 942663
7 XBRL TAXONOMY EXTENSION SCHEMA cenb-20180930.xsd EX-101.SCH 69111
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20180930_cal.xml EX-101.CAL 30168
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20180930_def.xml EX-101.DEF 414858
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20180930_lab.xml EX-101.LAB 300070
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20180930_pre.xml EX-101.PRE 442462
Mailing Address 20 N REAR RD LAKESHORE A6 N0R 1A0
Business Address 20 N REAR RD LAKESHORE A6 N0R 1A0 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 181176238
SIC: 2834 Pharmaceutical Preparations